BroadOak Capital Partners

BroadOak Capital Partners focuses on life sciences, providing investment and advisory services to portfolio companies. It operates via direct investments through BroadOak Asset Management and investment banking services through BroadOak Partners. The firm targets life sciences tools, diagnostics, and biopharma services, including cell and gene therapy, single-cell genomics, and life sciences software. It has advised on numerous M&A transactions and invested in a wide range of companies, leveraging deep industry expertise and networks to support growth in the $210 billion life sciences market.